GUARNERI, VALENTINA
GUARNERI, VALENTINA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials
2001 Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E.
New combinations with epirubicin in advanced breast cancer.
2001 Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C.
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).
2001 Bengala, C; Pazzagli, I; Innocenti, F; Donati, S; Favre, C; Menconi, Mc; Greco, F; Danesi, R; Orlandini, C; Guarneri, Valentina; Del Tacca, M; Conte, Pierfranco
Rischio neoplastico post-trapianto
2001 C., Bengala; Guarneri, Valentina; I., Pazzagli
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
2002 Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
2003 Bengala, C; Danesi, R; Guarneri, Valentina; Pazzagli, I; Donati, S; Favre, C; Fogli, S; Biadi, O; Innocenti, F; Del Tacca, M; Mariani, M; Conte, Pierfranco
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
2004 Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici
2004 M., Dominici; Guarneri, Valentina; L., Cafarelli; Conte, Pierfranco
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial
2004 Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini
The curability of breast cancer and the treatment of advanced disease
2004 Guarneri, Valentina; Conte, Pierfranco
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
2004 Conte, Pierfranco; Guarneri, Valentina
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years
2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
2005 C., Bengala; Guarneri, Valentina; E., Giovannetti; M., Lencioni; E., Fontana; V., Mey; A., Fontana; U., Boggi; M., Del Chiaro; R., Danesi; S., Ricci; F., Mosca; M., Del Tacca; Conte, Pierfranco
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005 Conte, Pierfranco; S., Donati; A., Gennari; Guarneri, Valentina; C., Orlandini; M., Rondini; M., Roncella; L., Marini; P., Collecchi; P., Viacava; A. G., Naccarato; R., DEGLI ESPOSTI; S., Bonardi; A., Bottini; S., Saracchini; S., Tumolo; G., Gullo; A., Santoro; L., Crino
High dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transpalntation (EBMT)
2005 C., Bengala; Guarneri, Valentina; J., Ledermann; G., Rosti; H., Wandt; Jp, Lotz; Jh, Cure; C., Orlandini; P., Ferrante; Conte, Pierfranco; T., Demirer
The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View
2005 Balla, J.; Lugassy, G.; Berenson, J.; Jackson, G.; Conte, Pierfranco; Guarneri, Valentina; Body, Jj
Renal safety and efficacy of intravenous bisphosphonates in patients with skeletal metastases treated for up to ten years
2005 Guarneri, Valentina; S., Donati; M., Nicolini; S., Giovannelli; R., D'Amico; Conte, Pierfranco
In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens
2005 Conte, Pierfranco; Guarneri, Valentina
Predictive value of biological parameters for primary chemotherapy in operable breast cancer
2005 A., Frassoldati; M., Maur; Guarneri, Valentina; M., Nicolini; Conte, Pierfranco